Sagittarius Life Science (3205) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sagittarius Life Science (3205) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$125.00K ≈ $3.94K USD) by net assets (NT$1.06 Billion ≈ $33.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sagittarius Life Science - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Sagittarius Life Science's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Sagittarius Life Science total liabilities for a breakdown of total debt and financial obligations.
Sagittarius Life Science Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sagittarius Life Science ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Moller Y Perez
SN:MOLLER
|
-0.017x |
|
MaxsMaking Inc. Class A Ordinary Shares
NASDAQ:MAMK
|
N/A |
|
Bionet
TWO:1784
|
0.038x |
|
Noroo Paint
KO:090350
|
-0.006x |
|
Komelon Corporation
KQ:049430
|
0.017x |
|
Leadtrend Technology Corp
TW:3588
|
0.010x |
|
Ratnaveer Precision Engineering Ltd
NSE:RATNAVEER
|
N/A |
|
Madras Fertilizers Limited
NSE:MADRASFERT
|
13.143x |
Annual Cash Flow Conversion Efficiency for Sagittarius Life Science (2015–2024)
The table below shows the annual cash flow conversion efficiency of Sagittarius Life Science from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Sagittarius Life Science (3205) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$419.76 Million ≈ $13.22 Million |
NT$-44.48 Million ≈ $-1.40 Million |
-0.106x | +19.51% |
| 2023-12-31 | NT$526.90 Million ≈ $16.60 Million |
NT$-69.37 Million ≈ $-2.19 Million |
-0.132x | -13.36% |
| 2022-12-31 | NT$455.42 Million ≈ $14.35 Million |
NT$-52.89 Million ≈ $-1.67 Million |
-0.116x | -111.62% |
| 2021-12-31 | NT$531.71 Million ≈ $16.75 Million |
NT$-29.18 Million ≈ $-919.36K |
-0.055x | +48.12% |
| 2020-12-31 | NT$588.38 Million ≈ $18.54 Million |
NT$-62.24 Million ≈ $-1.96 Million |
-0.106x | +31.72% |
| 2019-12-31 | NT$674.50 Million ≈ $21.25 Million |
NT$-104.50 Million ≈ $-3.29 Million |
-0.155x | -113.51% |
| 2018-12-31 | NT$797.37 Million ≈ $25.12 Million |
NT$-57.86 Million ≈ $-1.82 Million |
-0.073x | -200.52% |
| 2017-12-31 | NT$965.47 Million ≈ $30.42 Million |
NT$-23.31 Million ≈ $-734.49K |
-0.024x | -108.12% |
| 2016-12-31 | NT$1.21 Billion ≈ $38.18 Million |
NT$360.37 Million ≈ $11.35 Million |
0.297x | -10.68% |
| 2015-12-31 | NT$714.71 Million ≈ $22.52 Million |
NT$237.94 Million ≈ $7.50 Million |
0.333x | -- |
About Sagittarius Life Science
Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.